A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 15,727 shares of NVO stock, worth $1.37 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
15,727
Previous 16,421 4.23%
Holding current value
$1.37 Million
Previous $2.34 Million 20.1%
% of portfolio
0.52%
Previous 0.69%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $82,634 - $100,921
-694 Reduced 4.23%
15,727 $1.87 Million
Q2 2024

Aug 15, 2024

BUY
$122.71 - $146.91 $195,231 - $233,733
1,591 Added 10.73%
16,421 $2.34 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $279,679 - $372,284
2,739 Added 22.65%
14,830 $1.9 Million
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $434,072 - $521,450
4,945 Added 69.2%
12,091 $1.25 Million
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $454,790 - $997,899
5,001 Added 233.15%
7,146 $649,000
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $194,039 - $214,776
1,244 Added 138.07%
2,145 $347,000
Q1 2023

Jun 20, 2023

BUY
$132.34 - $159.14 $117,517 - $141,316
888 Added 6830.77%
901 $143,000
Q3 2022

Nov 15, 2022

BUY
$95.28 - $116.93 $1,238 - $1,520
13 New
13 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.